Quality Levels for Pre-fillable Syringes

Designed to meet specific drug product requirements

Choose the pre-fillable syringe quality most suited to YOUR requirements!

Meeting prevailing drug product requirements

For anticoagulants, WFI, diluents

Optimal choice for
highly sensitive drugs

For biotechs

For vaccines

Customized for extraordinary drug requirements

For drugs with custom requirements

Meeting Prevailing Drug Product Requirements

Anticoagulants | WFI | Diluents

Optimized processability for reduced TCO

Designed for reliable and safer manual administration

Standard data package for fast acceptance of goods

Inspection of SNS and RNS

Inspection of key dimensional and critical cosmetic quality aspects

Inspection of needle angularity and point

No glass-to-glass contact

Inspection of multiple flange criteria

Inspection of needle angularity and point

No glass-to-glass contact

Inspection of multiple flange criteria

Optimal Choice for Highly Sensitive Drugs

Biotechs

Excellent drug-container compatibility

Smooth integration into auto-injection devices

Optimized processability for high yield

Controlled low level of tungsten or tungsten-free

Low silicone amount with minimal tolerances

In-line inspection of homogeneous silicone distribution*

X-ray inspection of RNS*

Inspection of a wide range of strict dimensional and  cosmetic quality attributes

Laser-based cutting for higher mechanical strength

X-ray inspection of RNS*

Inspection of a wide range of strict dimensional and  cosmetic quality attributes

Laser-based cutting for higher mechanical strength

*Optional

Optimal Choice for Highly Sensitive Drugs

Vaccines

Precise control of attributes to ensure fast processability

 Designed for easier and safer vaccinations

Full data package for fast processing of goods

Controlled low level of tungsten or tungsten-free

Homogeneous silicone distribution for low variability in gliding and break-loose force

Inspection of needle angularity and point

Laser-based cutting for consistent flange thickness

Inspection of a wide range of strict dimensional and  cosmetic quality attributes

Inspection of flanges with guaranteed dimensions

Laser-based cutting for consistent flange thickness

Inspection of a wide range of strict dimensional and  cosmetic quality attributes

Inspection of flanges with guaranteed dimensions

*Optional

Customized for Extraordinary Drug Requirements

For drugs with custom requirements

Customize your syringe specifications
to meet extraordinary requirements that differ 

from the current quality levels

Go to article: Home | Big Tech meets Big PharmaGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: ProceedixGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: SanofiGo to article: ILC Dover Go to article: NiproGo to article: ACG WorldwideGo to article: CommentGo to article: Covid-19 vaccine effectiveness affected by variantsGo to article: Immuno-oncology high prescriber survey reveals top R&D strategiesGo to article: Using methotrexate may reduce the negative impact of high treatment-related costGo to article: Protecting against fake Covid-19 vaccinesGo to article: Cytiva Company Insight Go to article: CytivaGo to article: Datwyler Company Insight Go to article: DatwylerGo to article: In DepthGo to article: Is big pharma and big tech working together a recipe for success?Go to article: Logging in: how the pharma industry is getting to grips with social media Go to article: Medical cannabis: regulating a new export market on the Isle of ManGo to article: Long Covid: could chronic fatigue syndrome be taken seriously at last?Go to article: Life after Covid-19: four ways to prepare for the next pandemicGo to article: mRNA vaccines: the post-pandemic outlook after a breakthrough yearGo to article: Staving off AMR disaster with Ineos and the University of OxfordGo to article: Public benefit: could the PBC model help pharma balance profits and patients?Go to article: The Solubility Company Insight Go to article: The Solubility companyGo to article: ButterworthGo to article: MicronovaGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue